FDA.reportPublic FDA data

Cotempla 17.3 MG Disintegrating Oral Tablet

RxCUI
1926847
RxNorm name
Cotempla 17.3 MG Disintegrating Oral Tablet
Display name
Cotempla 17.3 MG Disintegrating Oral Tablet
Full name
Cotempla 17.3 MG Disintegrating Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
33f70f58-c871-42c8-8adb-345caeafefcdCotempla XR-ODT 17.3 MG Extended Release Disintegrating Oral Tablet [PSN] · methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] [SBD] · Cotempla 17.3 MG Disintegrating Oral Tablet [SY]315These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 195520250924